Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes
ConditionMyocardial Infarction (MI)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAl-Nahrain University
About this trial
The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad.
The main questions it aims to answer are:
How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complication rates, and recovery time in MI patients? What is the influence of hospital-related delays (e.g., time to intervention or reperfusion therapy) on the prognosis of MI patients?
Participants will:
Be monitored for the time elapsed from symptom onset to first medical contact and subsequent time intervals during hospital care.
Have their clinical outcomes, including in-hospital mortality, length of stay, and post-intervention complications, recorded and analyzed.
Eligibility criteria
Qualifiers
Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so).
Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI).
Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset.
Disqualifiers
Patients with non-acute myocardial infarction (e.g., stable angina, prior MI).
Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols.
Patients who are transferred to another facility before reperfusion therapy is initiated.
Pregnant women or breastfeeding women.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov